INTRODUCTION
Cholera toxin stimulates adenylate cyclase activity and tissue cyclic 3',5'-AMP in small intestinal mucosa, leukocytes, lymphocytes, platelets, fat cells, thyroid, and liver (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . The particular functional alterations produced by cholera toxin in each of these tissues presumably reflect those cellular functions under the control of cyclic 3',5'-AMP (4) . In contrast to other agents that act by stimulating adenylate cyclase, cholera toxin has Dr. Boyle was a Research Associate, National Institute of Allergy and Infectious Diseases.
Received for publication 15 August 1973 and in revised form 23 October 1973. generally been found not to increase adenylate cyclase activity in broken cell preparations obtained from tissues that, when intact, respond to cholera toxin (2, 8) . Furthermore, a substantial delay has been noted between the time at which tissue is first exposed to cholera toxin and the time at which an effect can be detected (2, 4, 7, 12) . Finally, the effect of cholera toxin has been difficult or impossible to reverse after exposing tissue to cholera toxin for a period as short as a few minutes and then removing the unbound toxin by adding antiserum or by washing the tissue (1, 2) . In an effort to begin to elucidate the basis of these characteristic features, we have studied directly the interaction of cholera toxin with intact lymphocytes obtained from rat thymus. Rat thymocytes constitute a particularly advantageous tissue because they can be obtained readily in large numbers, free of other cell types, without the use of digestive enzymes, and can be manipulated in vitro for as long as 6 h. We have also explored the sequence of events initiated by the interaction of cholera toxin with rat thymocytes, as well as the point in this sequence at which various pharmacologic agents act to alter the effect of cholera toxin on cell function. The following were provided as gifts: choleragen, choleragenoid, and equine antiserum to choleragenoid prepared by Dr. Richard Finkelstein and distributed by the Na- Preparation of thymocytes. Thymocyte suspensions were prepared according to the procedure of Goldfine, Gardner, and Neville (16) . Thymus glands were removed from suckling rats of either sex and were teased apart with dental forceps in 5 ml of buffer in a plastic petri dish.
METHODS
The standard buffer contained 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 2.5 mM MgC92, 1.5 mM NaH2PO4, 15 mM glucose, 25 mM Tris HCl (pH 7.5), and 5 mg/ml bovine serum albumin. After the glands were teased apart, the cells were filtered through nylon screen and then centrifuged at lOOg at 4°C for 10 mill. The leragen did not stimulate cellular accumulation of cyclic 3',5'-AMP or AIB influx. When rat thymocytes were incubated with PGE1 (10 M), cellular cyclic 3',5'-AMP increased by more than 50-fold during the first 3 min of incubation (Fig. 3) . Thereafter, cellular cyclic nucleotide levels decreased steadily and by 150 min of incubation were not significantly different from control Table III resuspending it in toxin-free solution. We found that after incubating thymocytes with ['I]choleragen, adding choleragen-specific antiserum or washing and resuspending the cells in choleragen-free medium produced only minimal dissociation of the bound tracer (approximately 10-15% by 100 min) (Fig. 4) . To estimate the apparent affinity of rat thymocytes for choleragen' we tested its ability to inhibit binding of [mI]choleragen (Fig. 5) . Half (Table III) .
Adding choleragen-specific antiserum to the thymocyte suspension just before adding [I]choleragen abolished binding of the labeled toxin (Table IV) . Antitoxin alone did not alter cellular cyclic 3',5'-AMP or AIB influx but abolished the stimulation of these two cellular functions by choleragen.
Since PGE5 and insulin have both been shown to stimulate AIB influx in rat thymocytes (16, 19) we were interested to see if either of these agents altered the effects of choleragen (Table IV) sum of the values obtained with each of these agents alone, i.e., the effects of insulin and choleragen on AIB influx were additive. (Table IV) .
DISCUSSION
The present results demonstrate directly that biologically active ['I]choleragen binds specifically to intact rat thymocytes in vitro and that binding is followed by a rise in cellular cyclic 3',5'-AMP that, in turn, is followed by stimulation of amino acid influx. Peterson, LoSpalluto, and Finkelstein (29) found that after exposing intestinal mucosa to choleragen, the toxin could be localized to the intestinal mucosa with immunohistochemical and autoradiographic techniques. Cholera toxin can also bind to intact sheep erythrocytes, since toxintreated cells agglutinate on exposure to cholera toxinspecific antiserum (30) . We have also found that ['I]-choleragen binds to human erythrocytes and to turkey erythrocytes; however, adding 10-7 M nonradioactive choleragen reduced binding by only 20%, indicating that the apparent affinity with which choleragen binds to these cells is lower than that observed in rat thymocytes, or that the binding sites are so abundant that they cannot be "saturated" at 10-7 M choleragen. Furthermore, human erythrocytes contain little or no adenylate cyclase activity, no detectable cyclic 3',5'-AMP (31), and do not respond to choleragen with changes in adenylate cyclase activity, sodium transport, or amino acid transport. Choleragen (10-7 M) also failed to stimulate adenylate cyclase or sodium transport in turkey erythrocytes, a tissue in which activation of adenylate cyclase produces a fourfold increase in sodium transport (32) . Thus, binding of choleragen to a particular tissue does not necessarily indicate that choleragen produces a functional alteration in that same tissue. Instead, evidence that choleragen binding mediates the alteration in cell function requires demonstration of a correlation between binding of choleragen and the choleragen-induced alteration of cell function.
The present studies also demonstrate that choleragen, once bound to the cell, dissociates very slowly, and confirm the previous conclusions of others based on studies of the effect of cholera toxin on cell function (1, 2, 4) . The slow rate of dissociation of ['uI] choleragen from the cells after addition of choleragen-specific antiserum cannot be attributed to an inability of the antibodies to bind cholera toxin, since antiserum could completely block binding of ['I]choleragen by rat thymocytes (Table IV) .
There ter the molecule so that it interacts only with the class of sites with low affinity for choleragen. This possibility, however, seems unlikely since choleragen iodinated with "2I was equipotent with native choleragen, and both agents stimulated cellular cyclic 3',5'-AMP and AIB influx at 10-' M (Table III) (34) (35) (36) .
In contrast to its effect on intestinal mucosa (10, 11) , choleragen produced only minimal changes in sodium and potassium transport in rat thymocytes. This is probably because cation transport in rat thymocytes is not under There was a substantial delay between cellular cyclic 3',5'-AMP accumulation and stimulation of amino acid transport. After 30 min of incubation with choleragen, cellular levels of cyclic 3',5'-AMP*were maximal while the increase in AIB influx was only 25% of that observed at 120 min (by which time cyclic 3',5'-AMP had decreased by 80%). A similar phenomenon was observed after stimulation by PGE1, indicating that this relation between cellular cyclic 3',5'-AMP and AIB influx is not peculiar to choleragen but instead is a property of the rat thymocyte.
Cycloheximide, an inhibitor of protein synthesis, did not alter ['I]choleragen binding or the time course of cellular cyclic 3',5'-AMP accumulation, but abolished choleragen-stimulated AIB influx. Thus, the mechanism through which cyclic 3',5'-AMP stimulates AIB influx may involve protein synthesis and this phenomenon may be the basis for the 90-min delay between maximal cyclic 3',5'-AMP accumulation and maximal stimulation of amino acid transport. There is also a delay between binding of insulin to thymocytes and stimulation of amino acid transport (via a mechanism not involving cyclic 3',5'-AMP [19] ) and the effect of insulin is abolished by cycloheximide (16) . In human leukocytes treated with cholera toxin there is no delay between accumulation of cyclic 3',5'-AMP and inhibition of histamine release (1) and cycloheximide does not alter the effect of choleragen on either of these functions (2). Kimberg, Field, Gershon, Schooley, and Henderson (37) have recently reported that in intestinal mucosa cycloheximide does not alter basal ion transport or cholera toxin stimulation of adenylate cyclase and cyclic 3',5'-AMP, but does inhibit the effect of the toxin on intestinal ion transport. Our finding, that cycloheximide reduces basal AIB transport in rat thymocytes, raises the possibility that protein synthesis is an integral part of the amino acid transport mechanism and that cyclic 3',5'-AMP (as well as insulin) may act not by stimulating protein synthesis directly but instead by stimulating a system whose normal operation requires protein synthesis. Thus, when protein synthesis is inhibited, the transport system is inhibited and is refractory to stimulation by cyclic 3',5'-AMP or insulin. Fi-nally, in plants (38) and bacteria (39) cycloheximide can alter other cellular metabolic processes besides protein synthesis; therefore, if similar effects occur in rat thymocytes, cycloheximide inhibition of amino acid transport may reflect alterations in cellular processes other than protein synthesis. Two experimental observations indicate that there may not be a quantitative relation between total cellular cyclic 3',5'-AMP and stimulation of AIB influx. In the presence of choleragenoid, choleragen-stimulated cellular cyclic 3',5'-AMP was reduced by 70% but AIB influx was decreased by only 30% (Table II) . It may be that in reponse to choleragen much more cyclic 3',5'-AMP is produced than is necessary for maximal stimulation of AIB influx. This phenomenon has been observed for other cyclic 3',5'-AMP-stimulated functions in other tissues (20, 32) and our results obtained with PGE1 and choleragen (Table IV) indicate that cellular cyclic 3',5'-AMP levels can be increased without a further increase in AIB influx. Alternatively, cyclic 3',5'-AMP may be compartmentalized within the cell, and only changes within a particular subcellular compartment produce changes in amino acid transport. This possibility is supported by results obtained with theophylline (Table IV) , which produced only a small increase in total cellular cyclic 3',5'-AMP but stimulated AIB influx to the same levels seen with choleragen or PGE1. Bourne, Lehrer, Lichtenstein, Weissmann, Zurier (2) observed an analogous effect of theophylline in human leukocytes, but concluded that theophylline might produce effects in leukocytes as it may in other tissues (20, 40 ) through a mechanism not involving cyclic 3',5'-AMP. The effects which we have observed with theophylline obviously do not exclude this possibility.
Several pharmacologic agents have been reported to alter the effect of choleragen on various tissues; however, the precise step at which these agents act has not been clearly delineated. Fig. 7 illustrates our conceptualization of the sequence of events involved in the mechanism of action of cholera toxin in rat thymocytes and the particular step in this sequence at which various pharmacologic agents may act to alter the response to choleragen. We have also depicted for comparison where PGE1 and insulin act in this sequence. Choleragenoid and choleragen-specific antiserum act to prevent the interaction of choleragen with specific cellular binding sites (probably located on the plasma membrane). The diuretic agent ethacrynic acid does not alter choleragen binding but reduces cellular levels of cyclic 3',5'-AMP and abolishes the stimulation of cyclic nucleotide levels by choleragen. Although in Fig. 7 we have indicated that ethacrynic acid inhibits synthesis of cyclic 3',5'-AMP, this is an unproved hypothesis and it is equally likely that ethacrynic acid stimulates degradation or disposition of cellular cyclic nucleotide. Polymyxin, an antibacterial agent with detergent properties, and cycloheximide act at some step after the accumulation of cyclic 3',5'-AMP to inhibit the stimulation of amino acid transport. PGE1 can also stimulate AIB influx in rat thymocytes by stimulating adenylate cyclase and increasing cellular cyclic 3',5'-AMP. Additive effects of 'PGE1 and choleragen were observed for stimulation of cellular cyclic 3',5'-AMP but not for stimulation if AIB transport. Insulin stimulates AIB influx by acting through a mechanism not involving cyclic 3',5'-AMP (19) . Insulin did not alter the effect of choleragen on cyclic 3',5'-AMP and the stimulation of AIB transport by insulin added to that produced by choleragen.
Addendum. Since this paper was submitted for publication, Cuatrecasas (41) (42) (43) (44) has reported that cholera toxin binds specifically to isolated fat cells (and to liver membranes) from the rat and that this binding correlates with cholera toxin-stimulated lipolysis. Choleragenoid inhibited binding of ['5I ]cholera toxin to liver membranes and did not stimulate lipolysis in fat cells, but blocked the stimulation of lipolysis by cholera toxin.
